Evidence map›Paper›PMID 42792911›Full record

ArticleGenes2026

Integrating Multi-Omics and Machine Learning to Reveal a Prognostic Model for Prostate Cancer Metastatic Recurrence Associated with Epithelial-Mesenchymal Transition Features.

Xueqian Zhang, Wei Zhang, Zheng Wang, Xinyang Shi, Chenghao Zhang, Yan Gao, Yiheng Deng, Tianyu Shen, Ziyan An, Weijun Fu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xueqian ZhangSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Wei ZhangSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Zheng WangDepartment of Urology, PLA General Hospital, Beijing 100039, China.
Xinyang ShiSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Chenghao ZhangSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Yan GaoSchool of Medical Technology, Hebei Medical University, Shijiazhuang 050031, China.
Yiheng DengSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Tianyu ShenSchool of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Ziyan AnDepartment of Urology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.ORCID 0000-0002-6054-1015
Weijun FuDepartment of Urology, PLA General Hospital, Beijing 100039, China.

Funding

National Natural Science Foundation of China 82270721the Beijing Natural Science Foundation 7252169
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorEpithelial-Mesenchymal TransitionMachine LearningNeoplasm Recurrence, LocalProstatic NeoplasmsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleMultiomicsNeoplasm MetastasisPrognosisTranscriptomeBiomarkers, Tumorepithelial–mesenchymal transitionmachine learningmulti-omics analysisprostate cancertumor microenvironment

Identifiers

PMID42792911
PMCPMC13606394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.